Adastra Labs Holdings Ltd. has launched its campaign on the Investing News Network’s cannabis channel.

Adastra Labs is in the process of becoming a standard cannabis processor and analytical testing lab in Canada. The company has already obtained its analytical testing license from Health Canada and expects to receive its standard processing license in the near term. The company owns a 13,000-square-foot former food packaging facility in British Columbia. The facility has been designed with good manufacturing practices (GMP) compliance in mind and is expected to feature a co-located in-process testing lab. The lab is expected to provide a full-spectrum of third-party analytical testing for licensed producers.


Adastra Labs plans to offer white label and toll processing services to cultivators looking to outsource their cannabis extraction and processing needs. The company also provides third-party cannabis testing services, which is a regulation that all licensed producers must adhere to. To date, the company has signed a supply agreement for dried flower and trim with SugarBud Craft Growers Corp. (TSXV:SUGR).

Adastra Labs’ company highlights include the following:

  • Adastra Labs aims to be a leading standard cannabis processor.
  • The company’s B2B strategy bridges the gap between cannabis cultivators and extraction.
  • Adastra Labs plans to be a one-stop-shop for cannabis concentrates.
  • The company owns a 13,000-square-foot facility in Langley, British Columbia, that is being built to GMP standards.
  • Supply agreement in place with SugarBud.
  • A highly diverse team of scientists, consultants and leaders lead Adastra Labs with strong collective experience in quality control and regulatory compliance in the cannabis industry.

Click here to see the educational profile for Adastra Labs and to request an investor presentation. 

Fundraising, Subscription by Directors and Love Hemp Q1 Trading Update

World High Life Plc (“World High Life” or the “Company”) (AQSE:LIFE) (OTCQB:WRHLF) announces that it has raised £566,206 via the issue of 56,620,600 ordinary shares of 1 pence each in the Company (“Ordinary Shares”; the “Subscription Shares”) at a subscription price of 1.0p per share. The proceeds of the Subscription Shares will be used by the Company for general working capital purposes

Keep reading... Show less

Global Wellness Strategies Inc. (formerly Redfund Capital Corp.) (CSE: LOAN) (FSE: O3X4) (OTCQB: PNNRD) (“Global” or the “Company”) announces it has signed a binding letter of intent (“BLOI”) on January 22, 2021 with EntheoTech Bioscience Inc. (“ET”) a wellness psilocybin leader based in Kelowna, British Columbia and will have the option to earn up to a 19.9% interest in ET.

EntheoTech is a Canadian bioscience company focused on the research and development of products, and protocols to promote brain health, performance optimization, and global wellness, using psychoactive substances such as psilocybin, medicinal mushrooms, and other natural products.

Keep reading... Show less

The new dispensary brings expanded access for patients along Florida’s Atlantic Coast

Trulieve Cannabis Corp. (CSE: TRUL)  (OTCQX: TCNNF) (“Trulieve” or “the Company”), a leading and top-performing cannabis company based in the United States announced today the opening of a brand-new Florida dispensary, the Company’s 78th nationwide. The new 4,600 sq. ft. location marks the Company’s first in the city of Sebastian and second in Indian River county expanding patient access to Florida’s largest and broadest assortment of high-quality medical cannabis products.

Keep reading... Show less

Canopy Growth Corporation (“Canopy Growth” or the “Company”) (TSX: WEED) (NASDAQ: CGC) will release its financial results for the third quarter fiscal 2021 ended December 31, 2020 before financial markets open on February 9, 2021.

Keep reading... Show less

NYSE | TSX: ACB

Aurora Cannabis Inc. (the “Company” or “Aurora”) (NYSE: ACB) (TSX: ACB), the Canadian company defining the future of cannabinoids worldwide, announced today the closing of its previously announced bought deal public offering (the “Offering”) of units of the Company (the “Units”) for total gross proceeds of US$137,940,000 . The Company sold 13,200,000 Units at a price of US$10.45 per Unit, including 1,200,000 Units sold pursuant to the exercise in full of the underwriters’ over-allotment option.

Keep reading... Show less